Tharimmune files 1-for-25 reverse stock split effective Nov 20 to meet Nasdaq's $1.00 bid price

Canton Strategic Holdings, Inc.

Reverse split ratio 1-for-25, effective Nov 20 at 4:01 pm ET; trading on post-split basis Nov 21 under THAR.
After split, approximately 700,474 shares of common stock outstanding.
Split approved by stockholders on Oct 23; final ratio set by the Board of Directors.
Primary purpose: regain compliance with Nasdaq's $1.00 minimum bid price for continued listing.
Fractional shares will be rounded up to the next whole share; proportionate adjustment to equity awards.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Canton Strategic Holdings, Inc.: Filing of Certificate of Amendment to effect a 1-for-25 reverse stock split (effective 2023-11-20).

Change: charter amendment
Effective: 2023-11-20

Exact text from the filing

On November 17, 2023, Tharimmune, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware pursuant to which it effected a 1-for-25 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Split”).

View on SEC.gov

Browse all governance changes →

Canton Strategic Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-041873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.